During our recent webinar, “mHealth + Patient Engagement: A New Connected Health Model”, our panelists, Dan Bender (Empatica), Larry Suarez (Oracle) and Jaime Cohen (BBK Worldwide) received many thought-provoking questions throughout the hour. While we were able to answer a few on the spot, there were many that we didn’t have time to address. Below, Jaime takes a turn answering your burning questions.
If you missed our webinar it’s not too late to download the recording. And now without further delay…
Can feedback obtained through mobile health technologies impact the way future trials are designed?
The short answer is yes. Any patient feedback – regardless of the source, is incredibly useful. Staying in tune to what's relevant to your patient population is paramount. Applying these insights to make study design, outreach tactics, interactions and engagements more patient-centric will only further enhance the patient's experience and result in increased retention. While patients are encouraged to provide feedback through focus groups, patient interviews or research, mobile health technologies of today are giving us – through user’s permission of course, unprecedented access to data on a personal scale. This level of insight is opening new doors, changing more than just study design but how we interact with patients on whole.
What is the average cost for adding a mHealth component to a clinical trial?
Beyond the FDA, will mHealth impact international regulatory hurdles and if so, how?
What value does mHealth bring to the patient's study experience?
As mobile health technology continues to evolve, more questions around its use within clinical trials will no doubt arise. Please continue to check back on the blog for more insights on mHealth + patient engagement and in the meantime, download our free eBook that delves deeper into how mobile health technology supports patient engagement and recruitment.